Ameriprise Financial Inc Ligand Pharmaceuticals Inc Transaction History
Ameriprise Financial Inc
- $375 Billion
- Q4 2024
A detailed history of Ameriprise Financial Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 95,704 shares of LGND stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,704
Previous 93,945
1.87%
Holding current value
$10.7 Million
Previous $9.41 Million
8.97%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding LGND
# of Institutions
276Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$322 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$234 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$114 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$99.2 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$83.4 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.89B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...